R01 HL098228/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2010	2
2011	5
2012	2
2013	3
2014	8
2015	6
2016	12
2017	9
2018	9
2019	4
2020	5
2021	2
2024	0

1

Fibrocytes: A Critical Review and Practical Guide.

Reinhardt JW, Breuer CK. Reinhardt JW, et al. Front Immunol. 2021 Dec 17;12:784401. doi: 10.3389/fimmu.2021.784401. eCollection 2021. Front Immunol. 2021. PMID: 34975874 Free PMC article. Review.

2

The Heart and Great Vessels.

Onwuka E, King N, Heuer E, Breuer C. Onwuka E, et al. Cold Spring Harb Perspect Med. 2018 Mar 1;8(3):a031922. doi: 10.1101/cshperspect.a031922. Cold Spring Harb Perspect Med. 2018. PMID: 28289246 Free PMC article. Review.

3

Cardiovascular Tissue Engineering: Preclinical Validation to Bedside Application.

Best C, Onwuka E, Pepper V, Sams M, Breuer J, Breuer C. Best C, et al. Physiology (Bethesda). 2016 Jan;31(1):7-15. doi: 10.1152/physiol.00018.2015. Physiology (Bethesda). 2016. PMID: 26661524 Free PMC article. Review.

4

Tissue-engineered vascular grafts for congenital cardiac disease: Clinical experience and current status.

Drews JD, Miyachi H, Shinoka T. Drews JD, et al. Trends Cardiovasc Med. 2017 Nov;27(8):521-531. doi: 10.1016/j.tcm.2017.06.013. Epub 2017 Jun 21. Trends Cardiovasc Med. 2017. PMID: 28754230 Free PMC article. Review.

5

Imatinib attenuates neotissue formation during vascular remodeling in an arterial bioresorbable vascular graft.

Miyachi H, Tara S, Otsuru S, Yi T, Lee YU, Drews JD, Nakayama H, Miyamoto S, Sugiura T, Shoji T, Breuer CK, Shinoka T. Miyachi H, et al. JVS Vasc Sci. 2020;1:57-67. doi: 10.1016/j.jvssci.2020.03.002. Epub 2020 Apr 11. JVS Vasc Sci. 2020. PMID: 34223286 Free PMC article.

6

Toward a patient-specific tissue engineered vascular graft.

Best C, Strouse R, Hor K, Pepper V, Tipton A, Kelly J, Shinoka T, Breuer C. Best C, et al. J Tissue Eng. 2018 Mar 16;9:2041731418764709. doi: 10.1177/2041731418764709. eCollection 2018 Jan-Dec. J Tissue Eng. 2018. PMID: 29568478 Free PMC article.

7

Zoledronate alters natural progression of tissue-engineered vascular grafts.

Chang YC, Li J, Mirhaidari G, Zbinden J, Barker J, Blum K, Reinhardt J, Best C, Kelly J, Shoji T, Yi T, Breuer C. Chang YC, et al. FASEB J. 2021 Oct;35(10):e21849. doi: 10.1096/fj.202001606RR. FASEB J. 2021. PMID: 34473380 Free PMC article.

8

Optimization of Tissue-Engineered Vascular Graft Design Using Computational Modeling.

Szafron JM, Ramachandra AB, Breuer CK, Marsden AL, Humphrey JD. Szafron JM, et al. Tissue Eng Part C Methods. 2019 Oct;25(10):561-570. doi: 10.1089/ten.TEC.2019.0086. Epub 2019 Sep 3. Tissue Eng Part C Methods. 2019. PMID: 31218941 Free PMC article.

9

Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again.

Patterson JT, Gilliland T, Maxfield MW, Church S, Naito Y, Shinoka T, Breuer CK. Patterson JT, et al. Regen Med. 2012 May;7(3):409-19. doi: 10.2217/rme.12.12. Regen Med. 2012. PMID: 22594331 Free PMC article. Review.

10

A mouse model of endocardial fibroelastosis.

Clark ES, Pepper VK, Best CA, Onwuka EA, Yi T, Tara S, Cianciolo R, Baker P, Shinoka T, Breuer CK. Clark ES, et al. Cardiovasc Pathol. 2015 Nov-Dec;24(6):388-94. doi: 10.1016/j.carpath.2015.08.002. Epub 2015 Aug 8. Cardiovasc Pathol. 2015. PMID: 26363814 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year